語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Practical pharmacology for Alzheimer...
~
SpringerLink (Online service)
Practical pharmacology for Alzheimer's disease
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Practical pharmacology for Alzheimer's disease/ by Takashi Kudo ... [et al.].
其他作者:
Kudo, Takashi.
出版者:
Cham :Springer International Publishing : : 2016.,
面頁冊數:
viii, 141 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Alzheimer's disease. -
電子資源:
http://dx.doi.org/10.1007/978-3-319-26206-2
ISBN:
9783319262062
Practical pharmacology for Alzheimer's disease
Practical pharmacology for Alzheimer's disease
[electronic resource] /by Takashi Kudo ... [et al.]. - Cham :Springer International Publishing :2016. - viii, 141 p. :ill., digital ;24 cm.
Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
ISBN: 9783319262062
Standard No.: 10.1007/978-3-319-26206-2doiSubjects--Topical Terms:
581461
Alzheimer's disease.
LC Class. No.: RC523
Dewey Class. No.: 616.831
Practical pharmacology for Alzheimer's disease
LDR
:02083nam a2200313 a 4500
001
862702
003
DE-He213
005
20160822115934.0
006
m d
007
cr nn 008maaau
008
170720s2016 gw s 0 eng d
020
$a
9783319262062
$q
(electronic bk.)
020
$a
9783319262048
$q
(paper)
024
7
$a
10.1007/978-3-319-26206-2
$2
doi
035
$a
978-3-319-26206-2
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC523
072
7
$a
MMGW
$2
bicssc
072
7
$a
MED105020
$2
bisacsh
082
0 4
$a
616.831
$2
23
090
$a
RC523
$b
.P895 2016
245
0 0
$a
Practical pharmacology for Alzheimer's disease
$h
[electronic resource] /
$c
by Takashi Kudo ... [et al.].
260
$a
Cham :
$c
2016.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
viii, 141 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
520
$a
The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
650
0
$a
Alzheimer's disease.
$3
581461
650
0
$a
Alzheimer's disease
$x
Chemotherapy.
$3
677833
650
0
$a
Alzheimer's disease
$x
Treatment.
$3
791237
650
0
$a
Drugs
$x
Effectiveness.
$3
1061059
650
1 4
$a
Medicine & Public Health.
$3
593949
650
2 4
$a
Psychopharmacology.
$3
644799
650
2 4
$a
Neurology.
$3
593894
650
2 4
$a
Pharmacotherapy.
$3
973587
700
1
$a
Kudo, Takashi.
$3
1106211
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-26206-2
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入